# Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

> **NCT02247232** · PHASE3 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 793 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Z-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02247232
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2021-06-29
- **Final completion:** 2022-02-25
- **Target enrollment:** 793 (ACTUAL)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247232, "Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02247232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*